Natco Pharma Ltd.
Snapshot View

View in App

Prices View details >>

546.70 +7.70 ▲1.4%

21 March 2023, 04:01:00 PM
Volume: 5,677

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.natcopharma.co.in
Market Cap 9,980.40 Cr.
Enterprise Value(EV) 9,630.00 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 21.31 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 25.66 Trailing Twelve Months Ending 2022-12
Industry PE 31.70 Trailing Twelve Months Ending 2022-12
Book Value / Share 253.82 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.15 Calculated using Price: 546.70
Dividend Yield 0.82 Period Ending 2022-03
No. of Shares Subscribed 18.26 Cr. 182,557,165 Shares
FaceValue 2
Company Profile
Natco Pharma is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). It is also engaged in contract manufacturing business, whereby it undertake selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. It has diversified into the business of crop health sciences to leverage is skills in organic chemistry.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.43%
1 Week
+1.37%
1 Month
-0.23%
3 Month
-2.90%
6 Month
-14.42%
1 Year
-32.43%
2 Year
-32.56%
5 Year
-30.04%
10 Year
+543.71%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.58 16.57 14.62 33.21 29.70 19.75 12.71 11.27 4.06
Return on Capital Employed (%) 18.02 15.62 18.04 39.21 35.28 23.71 14.82 13.99 4.86
Return on Assets (%) 8.62 10.10 9.72 23.43 23.05 16.02 10.30 9.43 3.43

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 726 846 1,296 1,649 3,072 3,489 3,774 4,122 4,264 4,571
Non Curr. Liab. 151 119 28 38 47 83 118 143 135 106
Curr. Liab. 312 414 493 627 592 729 685 526 710 401
Minority Int. 7 5 5 4 4 2 11 2
Equity & Liab. 1,196 1,384 1,822 2,318 3,715 4,303 4,588 4,792 5,109 5,078
Non Curr. Assets 828 901 985 1,230 1,584 1,956 2,262 2,447 2,612 2,675
Curr. Assets 368 483 837 1,087 2,131 2,347 2,326 2,345 2,497 2,403
Misc. Exp. not W/O
Total Assets 1,196 1,384 1,822 2,318 3,715 4,303 4,588 4,792 5,109 5,078

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 739 825 1,141 2,020 2,185 2,095 1,915 2,052 1,945 2,406
Other Income 17 15 10 14 40 130 107 106 99 89
Total Income 756 840 1,151 2,034 2,225 2,225 2,022 2,158 2,044 2,495
Total Expenditure -560 -612 -869 -1,337 -1,256 -1,300 -1,332 -1,448 -1,681 -1,828
PBIDT 196 228 283 697 969 925 690 710 363 667
Interest -37 -32 -23 -19 -15 -19 -22 -13 -18 -19
Depreciation -30 -47 -51 -54 -66 -81 -100 -117 -143 -161
Taxation -31 -4 -53 -140 -192 -182 -111 -137 -32 -99
Exceptional Items -15
PAT 98 130 156 485 695 642 458 442 170 389
Minority Interest 5 4 1 1 1 2 3 -2
Share Associate
Other Related Items
Consolidated Net Profit 103 135 157 486 696 644 461 441 170 389
Adjusted EPS 6 8 9 28 38 35 25 24 9 21

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 61 144 93 112 346 464 669 417 299 47
Cash Fr. Inv. -107 -109 -115 -176 -299 -1,116 -612 -167 -103 -5
Cash Fr. Finan. 26 -35 29 154 -48 651 -51 -251 -186 35
Net Change -20 0 7 91 -1 -1 6 -1 10 76
Cash & Cash Eqvt 10 10 12 -74 24 22 28 20 26 111

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 48.91 48.87 48.87 48.87 48.86 48.81 48.80 48.80 48.82
Public 51.09 51.13 51.13 51.13 51.14 51.19 51.20 51.20 51.18
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 21 Mar 2023
Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the equity shares bought-back on March 21 2023. Total no. of equity shares bought back are 55000
Mon, 20 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of share Certificate
Fri, 17 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
intimation for issue of duplicate share certificate

Technical Scans View Details >>

Tue, 21 Mar 2023
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Year High Decrease in 1 Year
Close Crossing 50 SMA From Below Close Crossing 50 SMA From Below
Closing Near 20 SMA Closing Near 20 SMA

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,419.30 -0.5%
Divi's Laboratories Ltd. 73,553.38 2,773.45 -0.9%
Cipla Ltd. 69,632.88 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. 51,277.87 1,518.00 -0.3%
Zydus Lifesciences Ltd. 48,378.30 477.95 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-12 26.39 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 477.95 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-12 3.07 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 477.95 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 0.04 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 477.95 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 21,763.34 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 477.95 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 2,559.47 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 477.95 +0.4%

FAQ's On Natco Pharma Ltd.

What is Natco Pharma share price?
Can I buy Natco Pharma shares now?
What is the Dividend Yield of Natco Pharma?
What is the Market Cap of Natco Pharma?
What are the key metrics to analyse Natco Pharma?
What is the 52 Week High and Low of Natco Pharma?
What is the trend of Natco Pharma share price?